Stroud, Clare
Onnela, Jukka-Pekka
Manji, Husseini
Article History
Received: 17 December 2018
Accepted: 6 May 2019
First Online: 3 June 2019
Competing interests
: H.M. is an employee of Janssen, which has ongoing programs to identify and validate biosignatures from patient derived digital data for early detection, patient stratification, drug efficacy measurement and prediction of disease progression and relapse in various neuroscience disorders. J.P.O. receives research funding from the National Institutes of Health, Mindstrong, and Otsuka Pharmaceutical Co., Ltd. C.S. is an employee of the National Academies of Sciences, Engineering, and Medicine; funding for the National Academies’ Neuroscience Forum comes from multiple private and public sources, which are listed in the acknowledgements.